Showing results (21-30 of 645) with videos related to
Sort By:
Pageof 65
Biochimica Et Biophysica Acta|July 26, 1982
Purification and characterization of human C1-esterase inhibitorT Nilsson, B WimanBiochimica Et Biophysica Acta|July 20, 1990
Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasmaO Sigurdardóttir, B WimanLakartidningen|January 9, 1991
[New methods accelerate the development of thrombolytic agents]B Wiman, A HamstenBiochimica Et Biophysica Acta|February 23, 1989
Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned mediumT Lindahl, B WimanEuropean Journal of Biochemistry|October 15, 1975
Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chainsB Wiman, P WallénThe American Journal of Cardiology|November 6, 1990
Correlations between fibrinolytic function and acute myocardial infarctionB Wiman, A HamstenBiochimica Et Biophysica Acta|September 21, 1994
Identification of a PAI-1 binding site in vitronectinO Sigurdardottir, B WimanScandinavian Journal of Clinical and Laboratory Investigation|December 1, 1998
Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexesA Nordenhem, B WimanActa Medica Scandinavica. Supplementum|January 1, 1984
Plasminogen content in diabetic woundsB Wiman, F LithnerScandinavian Journal of Clinical and Laboratory Investigation|August 1, 1997
Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 geneA Nordenhem, B WimanPageof 65